Priyom Bose, PhD
Priyom Bose holds a PhD in plant biology and biotechnology from the University of Madras, India. She is an experienced academic researcher and science writer. Priyom has co-authored several original research articles that have been published in reputed peer-reviewed journals and has also written extensively on a wide range of topics, such as life science, medicine, nanotechnology, agriculture and environmental sciences, etc. She is also an avid reader and an amateur photographer.
Latest Content
Article
Biopharma Analysis
Various biopharmaceutical analysis techniques are used to gain vital insights into the composition, quality, stability and safety of complex biotherapeutics throughout the development pipeline. In this article, we take a closer look at some of the strategies employed by scientists in the field.
Listicle
A Closer Look at Biomanufacturing
Download this listicle to discover the origins and development of biomanufacturing, key steps in the biomanufacturing process and the future of biomanufacturing.
Article
The Role of DNA Methylation in Human Disease
DNA methylation is one of the earliest epigenetic modifications to be discovered in human beings. Here we highlight some of the diseases caused by aberrant DNA methylation.
Article
COVID-19 Vaccine Research
Severe acute respiratory syndrome coronavirus-2, the causal agent of the ongoing coronavirus pandemic, has been evolving ever since the first outbreak in December 2019. Researchers believe that rapid vaccination is the most effective strategy to contain the pandemic.
Article
COVID-19 Vaccines and Therapeutic Development
Scientists are concerned about the emergence of SARS-CoV-2 variants and whether existing vaccines will remain effective against them. Hence, the development of robust therapeutic systems, such as repurposing drugs, could aid in managing the pandemic more efficiently. This article discusses the different vaccines and potential treatments developed thus far.
Article
Vaccine Production: Navigating Scale-Up Challenges
The transition from manufacturing vaccines in smaller quantities required for academic research to the mass production that is required to protect the global population can be a daunting task. In this article, we discuss key challenges related to the large-scale production of vaccines and also highlight ways to overcome these.
Advertisement
